Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)
Funding Opportunity PAR-19-304 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phase II (R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging or multiple chronic conditions in older people (e.g., sarcopenia, hearth failure with preserved ejection fraction (HFePF), immunosenescence, pulmonary fibrosis, metabolic syndrome, chronic kidney disease). This includes the...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2019 Category: Research Source Type: funding
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)
Funding Opportunity PAR-19-305 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging and/or multiple chronic conditions in older people (e.g., sarcopenia, heart failure with preserved ejection fraction (HFpEF), immunosenescence, metabolic syndrome, chronic kidney disease). This includes the dev...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2019 Category: Research Source Type: funding
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
Funding Opportunity PA-18-839 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction, and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reprodu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
Funding Opportunity PA-18-838 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction, and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reprodu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding
American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease and Cardiometabolic Disorders
Deadline: September 22, 2014 Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training. Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, ...
Source: ScanGrants feed - August 26, 2014 Category: Research Authors: American College of Cardiology Foundation Source Type: funding
DoD Peer Reviewed Orthopaedic Idea Development Award
Funding Opportunity Number: W81XWH-14-PRORP-IDA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 24, 2014Award Ceiling: Expected Number of Awards: 4Creation Date: Apr 30, 2014Funding Opportunity Description: The PRORP Idea Development Award...
Source: Grants.gov - May 1, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Peer Reviewed Orthopaedic Clinical Trial Development Award
Funding Opportunity Number: W81XWH-14-PRORP-CTDA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 24, 2014Award Ceiling: Expected Number of Awards: 4Creation Date: Apr 30, 2014Funding Opportunity Description: The PRORP CTDA is intended to s...
Source: Grants.gov - May 1, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Peer Reviewed Orthopaedic Clinical Trial Award
Funding Opportunity Number: W81XWH-14-PRORP-CTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 24, 2014Award Ceiling: Expected Number of Awards: 2Creation Date: Apr 30, 2014Funding Opportunity Description: The PRORP Clinical Trial Award i...
Source: Grants.gov - May 1, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Peer Reviewed Orthopaedic Translational Research Award
Funding Opportunity Number: W81XWH-14-PRORP-TRA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 24, 2014Award Ceiling: Expected Number of Awards: 2Creation Date: Apr 30, 2014Funding Opportunity Description: The PRORP Translational Research...
Source: Grants.gov - May 1, 2014 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease
Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training. Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hype...
Source: ScanGrants feed - May 6, 2013 Category: Research Authors: American College of Cardiology Foundation/Merck Source Type: funding
